The Scientific committee organises a number of one-day scientific meetings, webinars and the annual conference as well as joint meetings with other professional bodies each year. The topics of these meetings include a diverse variety of statistical techniques and applications relevant to PSI members working in clinical phase I-IV drug development & reimbursement and also a cover much wider remit applicable to the roles in the healthcare industry.
The Scientific Committee is composed of the following members:
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
R is quickly gaining popularity within the pharmaceutical industry due to it being a very powerful object-orientated language, and is able to produce analyses and high quality graphics. This will be a hands-on interactive course and will utilise the RStudio Cloud development environment.
In this talk we'll introduce the Grammar of Graphics, which allows you to compose graphs by combining independent components, and the implementation of this theory in R -- the ggplot2 package.
The format of this event will include Ted Talks by all of our speakers with the opportunity for us to have a discussion together after each of the presentations.
A year on after the final ICH E9 estimands addendum was published, we bring estimands to life. Members of the Estimands in Oncology special interest group will describe how the estimand framework provides a common language to describe the diversity of patient journeys and why it is important to address the right question in clinical trials.
This course will cover the essentials of DMC set up (roles and responsibilities, DMC charter, practical considerations), as well as discussing DMC case studies and the role of DMCs in adaptive trials and during the pandemic. In addition, there will be an interactive DMC workshop.
As a statistician in the Biostatistics and Programming Department, you will be responsible for the methodological and statistical aspects of projects in early clinical development in order to optimize the early development plan and ensure its coherence.
As a Director of Statistics, you will be accountable for guiding statisticians in their work, performing senior review of documentation and output deliveries, providing oversight and advising on best practices approach to statistics for clinical trials.
